XBiotech Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
XBiotech Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q2 2024.
  • XBiotech Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$15M, a 12.9% decline year-over-year.
  • XBiotech Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$42.9M, a 22.8% decline year-over-year.
  • XBiotech Inc. annual Operating Income (Loss) for 2023 was -$37.5M, a 8.76% decline from 2022.
  • XBiotech Inc. annual Operating Income (Loss) for 2022 was -$34.5M, a 37.5% decline from 2021.
  • XBiotech Inc. annual Operating Income (Loss) for 2021 was -$25.1M, a 37.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$42.9M -$15M -$1.71M -12.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$41.2M -$10.9M -$3.71M -51.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$37.5M -$8.59M -$426K -5.22% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$37.1M -$8.52M -$2.13M -33.4% Jul 1, 2023 Sep 30, 2023 10-K 2024-03-15
Q2 2023 -$35M -$13.3M -$1.16M -9.63% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$33.8M -$7.15M +$700K +8.92% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$34.5M -$8.16M -$969K -13.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$33.5M -$6.39M -$2.66M -71.2% Jul 1, 2022 Sep 30, 2022 10-K 2024-03-15
Q2 2022 -$30.9M -$12.1M -$1.49M -14% Apr 1, 2022 Jun 30, 2022 10-K 2024-03-15
Q1 2022 -$29.4M -$7.85M -$4.29M -121% Jan 1, 2022 Mar 31, 2022 10-K 2024-03-15
Q4 2021 -$25.1M -$7.19M -$2.27M -46.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$22.8M -$3.73M +$939K +20.1% Jul 1, 2021 Sep 30, 2021 10-K 2023-03-15
Q2 2021 -$23.8M -$10.6M -$4.09M -62.8% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-15
Q1 2021 -$19.7M -$3.55M -$1.38M -63.7% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-15
Q4 2020 -$18.3M -$4.92M +$8.39M +63% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$26.7M -$4.67M +$1.44M +23.6% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-15
Q2 2020 -$28.1M -$6.51M -$508K -8.46% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-15
Q1 2020 -$27.6M -$2.17M +$3.63M +62.6% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-15
Q4 2019 -$31.2M -$13.3M -$7.2M -118% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$24M -$6.11M -$996K -19.5% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-16
Q2 2019 -$23M -$6.01M -$385K -6.85% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-16
Q1 2019 -$22.6M -$5.81M -$1.66M -39.9% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-16
Q4 2018 -$21M -$6.11M +$1.4M +18.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$22.4M -$5.12M +$1.48M +22.4% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$23.9M -$5.62M +$4.07M +42% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$27.9M -$4.15M +$6.12M +59.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$34.1M -$7.51M +$8.93M +54.3% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-03-15
Q3 2017 -$43M -$6.59M +$5.87M +47.1% Jul 1, 2017 Sep 30, 2017 10-K/A 2019-03-15
Q2 2017 -$48.9M -$9.69M +$3.93M +28.8% Apr 1, 2017 Jun 30, 2017 10-K/A 2019-03-15
Q1 2017 -$52.8M -$10.3M -$23K -0.22% Jan 1, 2017 Mar 31, 2017 10-K/A 2019-03-15
Q4 2016 -$52.8M -$16.4M +$30.1M +64.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$82.9M -$12.5M -$23.3M -215% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$59.6M -$13.6M -$20M -312% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$39.6M -$10.2M -$2.04M -24.9% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$37.5M -$46.5M -$40.2M -628% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $2.64M $10.8M +$17.8M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$15.2M $6.42M +$10.3M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$25.5M -$8.21M -$3.7M -82.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$21.8M -$6.39M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$6.98M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$3.91M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$4.5M Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-06-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.